cy7 nhs ester Search Results


94
Cytiva Europe aureus
Aureus, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/Amersham+Cy7+NHS+Ester/pmc04558092-186-16-9
Average 94 stars, based on 1 article reviews
aureus - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
MedChemExpress cy7 nhs ester
( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with <t>Cy7-Mal.</t> ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.
Cy7 Nhs Ester, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/Cy7+NHS+ester/pmc13082320-292-5-13
Average 94 stars, based on 1 article reviews
cy7 nhs ester - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
GE Healthcare cy7 n hydroxysuccinimide nhs ester
( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with <t>Cy7-Mal.</t> ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.
Cy7 N Hydroxysuccinimide Nhs Ester, supplied by GE Healthcare, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/Cy7+NHS+Ester/pmc03479840-115-1-8
Average 96 stars, based on 1 article reviews
cy7 n hydroxysuccinimide nhs ester - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

93
MedChemExpress 3 tetramethylindocarbocyanine perchlorate dii
( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with <t>Cy7-Mal.</t> ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.
3 Tetramethylindocarbocyanine Perchlorate Dii, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/Cy7%2E5+NHS+ester/pm34958191__am1c20031_si_001-15-4-14
Average 93 stars, based on 1 article reviews
3 tetramethylindocarbocyanine perchlorate dii - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc cy7 nhs ester
( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with <t>Cy7-Mal.</t> ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.
Cy7 Nhs Ester, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy7+nhs+ester/pm36650558-137-6-9
Average 90 stars, based on 1 article reviews
cy7 nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Pharmacia Biotech Ltd cy7 nhs ester
( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with <t>Cy7-Mal.</t> ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.
Cy7 Nhs Ester, supplied by Amersham Pharmacia Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy7+nhs+ester/us11761877-443-38-21
Average 90 stars, based on 1 article reviews
cy7 nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ApexBio cy7 mono nhs ester
FnEVs aggravate clinical signs of DSS-induced acute colitis . (a) Experimental design outlining the DSS-induced colitis mice model and FnEVs treatment protocol. (b)Localization of FnEVs labeled with <t>Cy7</t> at 12 h after intragastric administration. (c) Photograph of the representative colon on day 10 after colitis induction. (d) Colon length was measured on day 10 after colitis induction. (e) Effect of FnEVs on the survival rate of DSS-treated mice. (f) Effect of FnEVs on the bodyweight of 3% DSS-treated mice. (g) clinical DAI was assessed following DSS exposure. (h) H&E staining, AB-PAS staining of colon sections on day 10 after colitis induction. Scale bar = 100 um. *p < .05, **p < .01, ***p < .001. All data were presented as the means ± SD (n = 6 mice per group). DSS, dextran sulfate sodium; DAI, disease activity index. H&E, hematoxylin and eosin; AB-PAS, Alcian blue-periodic acid-Schiff
Cy7 Mono Nhs Ester, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy7+mono+nhs+ester/pmc08007154-128-1-11
Average 90 stars, based on 1 article reviews
cy7 mono nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc cy7-di-nhs ester
FnEVs aggravate clinical signs of DSS-induced acute colitis . (a) Experimental design outlining the DSS-induced colitis mice model and FnEVs treatment protocol. (b)Localization of FnEVs labeled with <t>Cy7</t> at 12 h after intragastric administration. (c) Photograph of the representative colon on day 10 after colitis induction. (d) Colon length was measured on day 10 after colitis induction. (e) Effect of FnEVs on the survival rate of DSS-treated mice. (f) Effect of FnEVs on the bodyweight of 3% DSS-treated mice. (g) clinical DAI was assessed following DSS exposure. (h) H&E staining, AB-PAS staining of colon sections on day 10 after colitis induction. Scale bar = 100 um. *p < .05, **p < .01, ***p < .001. All data were presented as the means ± SD (n = 6 mice per group). DSS, dextran sulfate sodium; DAI, disease activity index. H&E, hematoxylin and eosin; AB-PAS, Alcian blue-periodic acid-Schiff
Cy7 Di Nhs Ester, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy7+di+nhs+ester/2R2829lM0ivDgITVEhiTw2bY8gkSWW4SAUKGWpF1f8rebAqkfe4aUBmO1ZE0TGkkIeQUQNQ1s0UOQJqwF-53-10-12
Average 90 stars, based on 1 article reviews
cy7-di-nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Click Chemistry Tools cy7 nhs ester
Localization of GPs in High-Fat-Diet-Fed Mice (A) Whole-body IVIS images of high-fat-diet-fed mice uninjected (left) and injected (right) with <t>Cy7-labeled</t> GPs. (B) Graph showing total radiant efficiency ([p/s]/[μW/cm 2 ]) of IVIS imaged organs (liver, spleen, kidney, and epidydimal adipose tissue). (C) Representative images of dissected organs (liver, spleen, kidney, and epidydimal adipose tissue) from uninjected and Cy7-tagged GPs injected obese mice. Data are means ± SEM, n = 3. Unpaired t test, *p < 0.05 compared to uninjected high-fat-diet-fed mice.
Cy7 Nhs Ester, supplied by Click Chemistry Tools, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy7+nhs+ester/pmc06526246-173-0-6
Average 90 stars, based on 1 article reviews
cy7 nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Life Sciences Inc engineered exosomes labeled with cy7 mono nhs ester
( A ) Biodistribution of hpMSC <t>exosomes</t> (MExo, 1 × 10 8 particles per mouse) and engineered exosomes (EExo, 1 × 10 9 particles per mouse) conjugated <t>with</t> <t>Cy7</t> mono NHS ester in the heart, lungs, liver, kidney, spleen, and bladder of mice, using ex vivo bioluminescence imaging assay, measured at 0, 2, 24, and 48 h after intraperitoneal administration. Data were obtained from 3 mice sacrificed at each time point in both groups. * p < 0.05, versus the 0-h mark. ( B ) Pharmacokinetic analysis of MExo and EExo. The plasma concentrations of MExo and EExo were measured through the assay of Cy7 mono NHS ester signal intensities. The MExo and EExo concentrations were measured at 0.5 h after intraperitoneal administration and were used as the baseline. Data were obtained from 3 mice in each group. hpMSC exosomes: exosomes from human placenta-derived mesenchymal stem cells. Engineered exosomes: engineered exosomes from RAW264.7 cells overexpressing hsa-let-7i-5p. The dashed line indicates a 50% fold change compared to the 4-h mark.
Engineered Exosomes Labeled With Cy7 Mono Nhs Ester, supplied by Amersham Life Sciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/engineered+exosomes+labeled+with+cy7+mono+nhs+ester/pmc11204613-83-44-53
Average 90 stars, based on 1 article reviews
engineered exosomes labeled with cy7 mono nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Amersham Pharmacia Biotech Ltd cy 7 nhs ester
( A ) Biodistribution of hpMSC <t>exosomes</t> (MExo, 1 × 10 8 particles per mouse) and engineered exosomes (EExo, 1 × 10 9 particles per mouse) conjugated <t>with</t> <t>Cy7</t> mono NHS ester in the heart, lungs, liver, kidney, spleen, and bladder of mice, using ex vivo bioluminescence imaging assay, measured at 0, 2, 24, and 48 h after intraperitoneal administration. Data were obtained from 3 mice sacrificed at each time point in both groups. * p < 0.05, versus the 0-h mark. ( B ) Pharmacokinetic analysis of MExo and EExo. The plasma concentrations of MExo and EExo were measured through the assay of Cy7 mono NHS ester signal intensities. The MExo and EExo concentrations were measured at 0.5 h after intraperitoneal administration and were used as the baseline. Data were obtained from 3 mice in each group. hpMSC exosomes: exosomes from human placenta-derived mesenchymal stem cells. Engineered exosomes: engineered exosomes from RAW264.7 cells overexpressing hsa-let-7i-5p. The dashed line indicates a 50% fold change compared to the 4-h mark.
Cy 7 Nhs Ester, supplied by Amersham Pharmacia Biotech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/cy+7+nhs+ester/us09828622-421-34-16
Average 90 stars, based on 1 article reviews
cy 7 nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ApexBio cyanine7 nhs ester
( A ) Biodistribution of hpMSC <t>exosomes</t> (MExo, 1 × 10 8 particles per mouse) and engineered exosomes (EExo, 1 × 10 9 particles per mouse) conjugated <t>with</t> <t>Cy7</t> mono NHS ester in the heart, lungs, liver, kidney, spleen, and bladder of mice, using ex vivo bioluminescence imaging assay, measured at 0, 2, 24, and 48 h after intraperitoneal administration. Data were obtained from 3 mice sacrificed at each time point in both groups. * p < 0.05, versus the 0-h mark. ( B ) Pharmacokinetic analysis of MExo and EExo. The plasma concentrations of MExo and EExo were measured through the assay of Cy7 mono NHS ester signal intensities. The MExo and EExo concentrations were measured at 0.5 h after intraperitoneal administration and were used as the baseline. Data were obtained from 3 mice in each group. hpMSC exosomes: exosomes from human placenta-derived mesenchymal stem cells. Engineered exosomes: engineered exosomes from RAW264.7 cells overexpressing hsa-let-7i-5p. The dashed line indicates a 50% fold change compared to the 4-h mark.
Cyanine7 Nhs Ester, supplied by ApexBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cy7+nhs+ester/near+infrared+cy7+nhs+ester/pm29323913-53-0-6
Average 90 stars, based on 1 article reviews
cyanine7 nhs ester - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with Cy7-Mal. ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.

Journal: Science Advances

Article Title: Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer

doi: 10.1126/sciadv.aeb9764

Figure Lengend Snippet: ( A ) Scheme of SH-EM-NP/EPI preparation. ( B ) Sizes and zeta potential of PLGA-NP/EPI, EM-NP/EPI, and SH-EM-NP/EPI. Data are presented as the means ± SD ( n = 3). Statistical analysis was performed using one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons test. *** P < 0.001; **** P < 0.0001. ( C ) A representative image of SH-EM-NP/EPI examined by TEM. Scale bar, 50 nm. ( D ) Free thiol content of nanoparticles with and without SH modification measured by the DTNB (Ellman’s reagent) assay ( n = 3). ( E ) Schematic diagram of SH-EM-NP/EPI labeled with Cy7-Mal. ( F ) Fluorescence images and corresponding mean fluorescence intensities of EM-NP/EPI and SH-EM-NP/EPI after 2 hours of incubation with Cy7-Mal, followed by centrifugation, washing, and resuspension ( n = 3). ( G ) The heatmap presents the abundance profiles of the top 50 high-abundance membrane proteins across the three independent SH-EM-NP/EPI sample batches. ( H ) Photos of SH-EM-NP/EPI lyophilized powder (left) and reconstituted solution (right). All samples were stored in nitrogen atmosphere. ( I ) Size of freshly prepared solution (FS) and reconstituted solution (RS) ( n = 3). ( J ) Free thiol content of FS and RS ( n = 3). In (D), (F), (I), and (J), the data are presented as the means ± SD. Statistical analysis was performed using two-tailed Student’s t test. **** P < 0.0001; n.s., not significant.

Article Snippet: Cy7 maleimide (CAS: 2120392-49-4) and Cy7 NHS Ester (CAS: 1432019-64-1) were purchased from MedChemExpress LLC (New Jersey, USA).

Techniques: Zeta Potential Analyzer, Modification, Labeling, Fluorescence, Incubation, Centrifugation, Membrane, Two Tailed Test

FnEVs aggravate clinical signs of DSS-induced acute colitis . (a) Experimental design outlining the DSS-induced colitis mice model and FnEVs treatment protocol. (b)Localization of FnEVs labeled with Cy7 at 12 h after intragastric administration. (c) Photograph of the representative colon on day 10 after colitis induction. (d) Colon length was measured on day 10 after colitis induction. (e) Effect of FnEVs on the survival rate of DSS-treated mice. (f) Effect of FnEVs on the bodyweight of 3% DSS-treated mice. (g) clinical DAI was assessed following DSS exposure. (h) H&E staining, AB-PAS staining of colon sections on day 10 after colitis induction. Scale bar = 100 um. *p < .05, **p < .01, ***p < .001. All data were presented as the means ± SD (n = 6 mice per group). DSS, dextran sulfate sodium; DAI, disease activity index. H&E, hematoxylin and eosin; AB-PAS, Alcian blue-periodic acid-Schiff

Journal: Gut Microbes

Article Title: Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway

doi: 10.1080/19490976.2021.1902718

Figure Lengend Snippet: FnEVs aggravate clinical signs of DSS-induced acute colitis . (a) Experimental design outlining the DSS-induced colitis mice model and FnEVs treatment protocol. (b)Localization of FnEVs labeled with Cy7 at 12 h after intragastric administration. (c) Photograph of the representative colon on day 10 after colitis induction. (d) Colon length was measured on day 10 after colitis induction. (e) Effect of FnEVs on the survival rate of DSS-treated mice. (f) Effect of FnEVs on the bodyweight of 3% DSS-treated mice. (g) clinical DAI was assessed following DSS exposure. (h) H&E staining, AB-PAS staining of colon sections on day 10 after colitis induction. Scale bar = 100 um. *p < .05, **p < .01, ***p < .001. All data were presented as the means ± SD (n = 6 mice per group). DSS, dextran sulfate sodium; DAI, disease activity index. H&E, hematoxylin and eosin; AB-PAS, Alcian blue-periodic acid-Schiff

Article Snippet: For Cy7 labeling, Cy7 mono NHS ester (Cyanine 7 monosuccinimidyl ester; APExBIO) was added into the EV-PBS to 5 μM and incubated for 30 min at 37 °C.

Techniques: Labeling, Staining, Activity Assay

Localization of GPs in High-Fat-Diet-Fed Mice (A) Whole-body IVIS images of high-fat-diet-fed mice uninjected (left) and injected (right) with Cy7-labeled GPs. (B) Graph showing total radiant efficiency ([p/s]/[μW/cm 2 ]) of IVIS imaged organs (liver, spleen, kidney, and epidydimal adipose tissue). (C) Representative images of dissected organs (liver, spleen, kidney, and epidydimal adipose tissue) from uninjected and Cy7-tagged GPs injected obese mice. Data are means ± SEM, n = 3. Unpaired t test, *p < 0.05 compared to uninjected high-fat-diet-fed mice.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Targeted SHP-1 Silencing Modulates the Macrophage Phenotype, Leading to Metabolic Improvement in Dietary Obese Mice

doi: 10.1016/j.omtn.2019.04.020

Figure Lengend Snippet: Localization of GPs in High-Fat-Diet-Fed Mice (A) Whole-body IVIS images of high-fat-diet-fed mice uninjected (left) and injected (right) with Cy7-labeled GPs. (B) Graph showing total radiant efficiency ([p/s]/[μW/cm 2 ]) of IVIS imaged organs (liver, spleen, kidney, and epidydimal adipose tissue). (C) Representative images of dissected organs (liver, spleen, kidney, and epidydimal adipose tissue) from uninjected and Cy7-tagged GPs injected obese mice. Data are means ± SEM, n = 3. Unpaired t test, *p < 0.05 compared to uninjected high-fat-diet-fed mice.

Article Snippet: Cy7 NHS ester was purchased from Click Chemistry Tools (AZ, USA).

Techniques: Injection, Labeling

( A ) Biodistribution of hpMSC exosomes (MExo, 1 × 10 8 particles per mouse) and engineered exosomes (EExo, 1 × 10 9 particles per mouse) conjugated with Cy7 mono NHS ester in the heart, lungs, liver, kidney, spleen, and bladder of mice, using ex vivo bioluminescence imaging assay, measured at 0, 2, 24, and 48 h after intraperitoneal administration. Data were obtained from 3 mice sacrificed at each time point in both groups. * p < 0.05, versus the 0-h mark. ( B ) Pharmacokinetic analysis of MExo and EExo. The plasma concentrations of MExo and EExo were measured through the assay of Cy7 mono NHS ester signal intensities. The MExo and EExo concentrations were measured at 0.5 h after intraperitoneal administration and were used as the baseline. Data were obtained from 3 mice in each group. hpMSC exosomes: exosomes from human placenta-derived mesenchymal stem cells. Engineered exosomes: engineered exosomes from RAW264.7 cells overexpressing hsa-let-7i-5p. The dashed line indicates a 50% fold change compared to the 4-h mark.

Journal: Journal of Personalized Medicine

Article Title: Therapeutic Effects of Engineered Exosomes from RAW264.7 Cells Overexpressing hsa-let-7i-5p against Sepsis in Mice—A Comparative Study with Human Placenta-Derived Mesenchymal Stem Cell Exosomes

doi: 10.3390/jpm14060619

Figure Lengend Snippet: ( A ) Biodistribution of hpMSC exosomes (MExo, 1 × 10 8 particles per mouse) and engineered exosomes (EExo, 1 × 10 9 particles per mouse) conjugated with Cy7 mono NHS ester in the heart, lungs, liver, kidney, spleen, and bladder of mice, using ex vivo bioluminescence imaging assay, measured at 0, 2, 24, and 48 h after intraperitoneal administration. Data were obtained from 3 mice sacrificed at each time point in both groups. * p < 0.05, versus the 0-h mark. ( B ) Pharmacokinetic analysis of MExo and EExo. The plasma concentrations of MExo and EExo were measured through the assay of Cy7 mono NHS ester signal intensities. The MExo and EExo concentrations were measured at 0.5 h after intraperitoneal administration and were used as the baseline. Data were obtained from 3 mice in each group. hpMSC exosomes: exosomes from human placenta-derived mesenchymal stem cells. Engineered exosomes: engineered exosomes from RAW264.7 cells overexpressing hsa-let-7i-5p. The dashed line indicates a 50% fold change compared to the 4-h mark.

Article Snippet: Also divided into two groups ( n = 3 in each group), the first group of mice received intraperitoneal injections of hpMSC exosomes labeled with Cy7 mono NHS ester (Amersham) (1 × 10 8 particles per mouse), and the second group of mice received engineered exosomes, also labeled with Cy7 mono NHS ester (Amersham) (1 × 10 9 particles per mouse).

Techniques: Ex Vivo, Imaging, Clinical Proteomics, Derivative Assay